Hsbc Holdings PLC Dyne Therapeutics, Inc. Transaction History
Hsbc Holdings PLC
- $159 Billion
- Q1 2025
A detailed history of Hsbc Holdings PLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 28,396 shares of DYN stock, worth $341,319. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,396
Previous 13,354
112.64%
Holding current value
$341,319
Previous $314,000
5.41%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding DYN
# of Institutions
217Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$124 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$117 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$110 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$89 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$88.8 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $622M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...